New Delhi: India’s pharma exports, currently valued at nearly $27.8 billion, are expected to cross $30 billion by the year-end, said Union Minister of State (Independent Charge) for Science and Technology Jitendra Singh on Tuesday.

Singh stated that India’s domestic pharma market is $60 billion, but is expected to double, that is, $130 billion by 2030.

He added that the Medtech sector will also witness growth.

“Currently, there are around 800 medical device manufacturers in the country, and India’s annual growth of the Medtech sector is 15 to 20 per cent,” said Singh.

He was speaking at the signing of an official Memorandum of Understanding (MoU) between the Department of Biotechnology (DBT) and the Government of Uttar Pradesh.

The agreement, executed through DBT’s Biotechnology Indus

See Full Page